We are live on ! Find out more
AQST icon

Aquestive Therapeutics

60 hedge funds and large institutions have $62M invested in Aquestive Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 23 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more call options, than puts

Call options by funds: $592K | Put options by funds: $428K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3.21% less ownership

Funds ownership: 45.91%42.7% (-3.2%)

5% less funds holding

Funds holding: 6360 (-3)

13% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 24

28% less capital invested

Capital invested by funds: $86.3M → $62M (-$24.3M)

52% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 23

Holders
60
Holders Change
-3
Holders Change %
-4.76%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
11
Reduced
23
Closed
24
Calls
$592K
Puts
$428K
Net Calls
+$164K
Net Calls Change
+$430K
Name Holding Trade Value Shares
Change
Change in
Stake
ASN
51
Advisory Services Network
Georgia
$3K +$3.19K +800 New
PAM
52
Panagora Asset Management
Massachusetts
$2K -$2.59K -648 -61%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$1K -$39.3K -9,841 -98%
CG
54
Cutler Group
California
$1K -$7.19K -1,800 -82%
NFG
55
Next Financial Group
Texas
$1K
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$877 -$9.08K -2,274 -91%
N
57
Nuveen
North Carolina
-$3.97M -764,217 Closed
Citadel Advisors
58
Citadel Advisors
Florida
-$301K -75,463 Closed
Massachusetts Financial Services
59
Massachusetts Financial Services
Massachusetts
-$283K -54,495 Closed
EGM
60
Engineers Gate Manager
New York
-$266K -51,200 Closed
California Public Employees Retirement System
61
California Public Employees Retirement System
California
-$215K -41,300 Closed
DCM
62
Dupont Capital Management
Delaware
-$191K -36,752 Closed
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
-$156K -29,960 Closed
GWM
64
Geneos Wealth Management
Colorado
-$94K -23,300 Closed
AQR Capital Management
65
AQR Capital Management
Connecticut
-$103K -19,786 Closed
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
-$98K -18,815 Closed
AllianceBernstein
67
AllianceBernstein
Tennessee
-$82K -15,800 Closed
OGC
68
Oak Grove Capital
New Hampshire
-$81K -15,500 Closed
CAMG
69
CWA Asset Management Group
Florida
-$72K -13,811 Closed
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
-$66K -12,689 Closed
TRCT
71
Tower Research Capital (TRC)
New York
-$62K -12,044 Closed
AIG
72
American International Group
New York
-$60 -11,581 Closed
Invesco
73
Invesco
Georgia
-$60K -11,557 Closed
XT
74
XTX Topco
Cayman Islands
-$57K -10,970 Closed
TI
75
Trexquant Investment
Connecticut
-$53K -10,227 Closed

AQST Hedge Fund Activity: Q2 2021 in Review

60 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q2 2021, worth a combined $62M — down 28% from $86.3M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of AQST and 21 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 11 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.75M. The largest seller was BlackRock, cutting an estimated $4.02M.

  • 60 institutional investors held Aquestive Therapeutics (AQST) as of Q2 2021, down from 63 in Q1 2021.
  • Funds reported $62M of Aquestive Therapeutics stock for Q2 2021, down 28% quarter-over-quarter.
  • 21 funds opened new Aquestive Therapeutics positions in Q2 2021 and 24 closed out, a net change of -3 holders.
  • The largest Aquestive Therapeutics buyer in Q2 2021 was Millennium Management, an estimated $1.75M added.
  • The largest Aquestive Therapeutics seller in Q2 2021 was BlackRock, an estimated $4.02M sold.

Based on aggregated 13F filings for Q2 2021.